Volume 27, Issue 9 pp. 1209-1215
Research Article
Free Access

Enhanced flexor tendon healing through controlled delivery of PDGF-BB

Stavros Thomopoulos

Corresponding Author

Stavros Thomopoulos

Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri

Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri, Telephone: 314-362-8605; Fax: 314-362-0334Search for more papers by this author
Rosalina Das

Rosalina Das

Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri

Search for more papers by this author
Matthew J. Silva

Matthew J. Silva

Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri

Search for more papers by this author
Shelly Sakiyama-Elbert

Shelly Sakiyama-Elbert

Department of Biomedical Engineering, Washington University, St. Louis, Missouri

Search for more papers by this author
Frederick L. Harwood

Frederick L. Harwood

Department of Orthopaedic Surgery, University of California San Diego, San Diego, California

Search for more papers by this author
Emmanouil Zampiakis

Emmanouil Zampiakis

Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri

Search for more papers by this author
H. Mike Kim

H. Mike Kim

Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri

Search for more papers by this author
David Amiel

David Amiel

Department of Orthopaedic Surgery, University of California San Diego, San Diego, California

Search for more papers by this author
Richard H. Gelberman

Richard H. Gelberman

Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri

Search for more papers by this author
First published: 25 March 2009
Citations: 97

Abstract

A fibrin/heparin-based delivery system was used to provide controlled delivery of platelet derived growth factor BB (PDGF-BB) in an animal model of intrasynovial flexor tendon repair. We hypothesized that PDGF-BB, administered in this manner, would stimulate cell proliferation and matrix remodeling, leading to improvements in the sutured tendon's functional and structural properties. Fifty-six flexor digitorum profundus tendons were injured and repaired in 28 dogs. Three groups were compared: (1) controlled delivery of PDGF-BB using a fibrin/heparin-based delivery system; (2) delivery system carrier control; and (3) repair- only control. The operated forelimbs were treated with controlled passive motion rehabilitation. The animals were euthanized at 7, 14, and 42 days, at which time the tendons were assessed using histologic (hyaluronic acid content, cellularity, and inflammation), biochemical (total DNA and reducible collagen crosslink levels), and biomechanical (gliding and tensile properties) assays. We found that cell activity (as determined by total DNA, collagen crosslink analyses, and hyaluronic acid content) was accelerated due to PDGF-BB at 14 days. Proximal interphalangeal joint rotation and tendon excursion (i.e., tendon gliding properties) were significantly higher for the PDGF-BB-treated tendons compared to the repair-alone tendons at 42 days. Improvements in tensile properties were not achieved, possibly due to suboptimal release kinetics or other factors. In conclusion, PDGF-BB treatment consistently improved the functional but not the structural properties of sutured intrasynovial tendons through 42 days following repair. © 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.